The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 350:1686-1687 April 15, 2004 Number 16
NextNext

A Trial of Antiparasitic Treatment for Cerebral Cysticercosis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Garcia, H. H.
-PubMed Citation
To the Editor: Garcia et al. (Jan. 15 issue)1 report the results of a trial of antiparasitic treatment for cerebral cysticercosis. Previous investigations, such as the one by Carpio et al.,2 have not shown differences among praziquantel, albendazole, and prednisolone in the treatment of neurocysticercosis or in the outcome of seizures related to it. I think the control group in the study by Garcia et al. should have been treated with dexamethasone or prednisolone. We know that albendazole in combination with dexamethasone is better than placebo. But is albendazole in combination with corticosteroids better than dexamethasone or prednisolone alone?


Ignacio . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.